5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease

5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease

5-Aminolevulinic acid (5-ALA) is a naturally occurring nonprotein amino acid licensed as an optical imaging agent for the treatment of gliomas. In recent years, 5-ALA has been shown to possess anti-inflammatory and immunoregulatory properties through upregulation of heme oxygenase-1 via enhancement...

Full description

Bibliographic Details
Main Authors: Vipul Yadav, Yang Mai, Laura E. McCoubrey, Yasufumi Wada, Motoyasu Tomioka, Satofumi Kawata, Shrikant Charde, Abdul W. Basit
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Biomedicines
Subjects:
ulcerative colitis
Crohn’s disease
inflammation
5 amino levulinic acid
colonic drug delivery
anti-inflammatory
Online Access:https://www.mdpi.com/2227-9059/9/5/578

Internet

https://www.mdpi.com/2227-9059/9/5/578

Similar Items